A 24-week, double-blind, parallel group, placebo and active controlled study to investigate the efficacy and safety of daily oral roflumilast taken with low dose inhaled corticosteroids in patients with chronic asthma.
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Corticosteroids; Roflumilast
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors AstraZeneca
- 04 May 2012 Company (Takeda Global Research and Development Center) added as trial sponsor as reported by ClinicalTrials.gov.
- 30 Oct 2005 New trial record.